CS logo
small CS logo
Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center

Shenzhen, Guangdong, China

About Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
2
Taizhou Hanzhong biomedical co. LTD
2
Fudan University
1
Herui Yao
1
Jacobio Pharmaceuticals Co., Ltd.
1
Janssen Research & Development, LLC
1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
1
Suzhou Junjing BioSciences Co., Ltd.
1
Waterstone Hanxbio Pty Ltd
1
Total Rows: 9

Clinical Trials at Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


During the past decade, Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
2016-11-14
2026-03-31
Recruiting
280
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
2018-05-01
2030-05-01
Recruiting
210
HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
2020-09-16
2023-08-10
Recruiting
560
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
2020-10-13
2025-01-31
Active, not recruiting
308
Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)
2021-01-07
2022-10-30
Unknown status
72
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
2021-08-01
2029-05-01
Enrolling by invitation
606
Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors
2021-05-12
2023-02-10
Active, not recruiting
210
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
2021-07-13
2024-08-18
Recruiting
156

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" #1 sponsor was "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials, followed by "Taizhou Hanzhong biomedical co. LTD" with 2 trials sponsored, "Fudan University" with 1 trials sponsored, "Herui Yao" with 1 trials sponsored and "Jacobio Pharmaceuticals Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" #1 collaborator was "GeneCast Biotechnology Co., Ltd." with 1 trials as a collaborator and "Jiangsu Hansoh Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCancer Institute andHospital, ChineseAcademy of MedicalSciences: 2Cancer Institute andHospital, ChineseAcademy of MedicalSciences: 2Taizhou Hanzhongbiomedical co. LTD: 2Taizhou Hanzhongbiomedical co. LTD: 2Fudan University: 1Fudan University: 1Herui Yao: 1Herui Yao: 1Jacobio PharmaceuticalsCo., Ltd.: 1Jacobio PharmaceuticalsCo., Ltd.: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Shanghai FosunPharmaceuticalIndustrial DevelopmentCo. Ltd.: 1Shanghai FosunPharmaceuticalIndustrial DevelopmentCo. Ltd.: 1Suzhou JunjingBioSciences Co., Ltd.: 1Suzhou JunjingBioSciences Co., Ltd.: 1Waterstone Hanxbio Pty Ltd: 1Waterstone Hanxbio Pty Ltd: 1

Created with Highcharts 11.1.0Top CollaboratorsGeneCastBiotechnology Co., Ltd.:1GeneCastBiotechnology Co., Ltd.:1Jiangsu HansohPharmaceutical Co.,Ltd.: 1Jiangsu HansohPharmaceutical Co.,Ltd.: 1

Clinical Trials Conditions at Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


According to Clinical.Site data, the most researched conditions in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" are "Advanced Solid Tumor" (2 trials), "Advanced Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" in a lesser frequency.

Clinical Trials Intervention Types at Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


Most popular intervention types in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" are "Drug" (10 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "HX008" (2 trials), "Pemetrexed" (2 trials), "Almonertinib" (1 trials), "Amivantamab" (1 trials) and "Anti-PD-1 Immune Checkpoint Inhibitors" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


The vast majority of trials in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center" are 9 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center


Currently, there are NaN active trials in "Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen center, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 5Phase 2: 5Phase 3: 4Phase 3: 4Phase 1: 3Phase 1: 3Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 6Recruiting: 6Active, not recruiting: 3Active, not recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1Unknown status: 1Unknown status: 1